Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus

References

• Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264:375–82.
   PubMed Web of Science ®Google Scholar
• Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev 1996;60:575–608.
   PubMedGoogle Scholar
• Thomson CJ. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective. J Antimicrob Chemother 1999;43(Suppl A):31–40.
   PubMedGoogle Scholar
• Kaatz GW, Seo SM, Ruble CA. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993;37:1086–94.
   PubMed Web of Science ®Google Scholar
• Farnsworth NR, Soejarto DD. Global importance of medicinal plants. Akerele O, Heywood V, Synge H. The conservation of medicinal plants. Cambridge: Cambridge University Press; 1991. 25–51.
   Google Scholar
• Ramachandra P, Basheermiya M, Krupadanam GLD, Srimanarayana G. Wrightial, a new terpene from Wrightia tinctoria. J Nat Prod 1993;56:1811–2.
   Google Scholar
• Krishnamoorthy JR, Ranganathan S. Antipityrosporum ovale activity of a herbal drug combination of Wrightia tinctoria and Hisbiscus rosasinensis. Ind J Dermatol 2000; 45:125–6.
   Google Scholar
• Shah GL, Gopal GV. Ethnomedical notes from the tribal inhabitants of the North Gujarat, India. J Eco Tax Bot 1988; 6:193–201.
   Google Scholar
• Reddy YS, Venkatesh S, Ravichandran T, Murugan V, Suresh B. Antinociceptive activity of Wrightia tinctoria bark. Fitoterapia 2002;73:421–3.
   PubMedGoogle Scholar
• Bigoniya P, Shukla A, Agrawal GP, Rana AC. Pharmacological screening of Wrightia tinctoria bark hydro-alcoholic extract. Asian J Exp Sci 2008;22:235–44.
   Google Scholar
• Kannan P, Shanmugavadivu B, Petchiammal C, Hopper W. In vitro antimicrobial activity of Wrightia tinctoria leaf extracts against skin microorganisms. Acta Bot Hung 2006;48:323–9.
   Google Scholar
• National Committee for Clinical and Laboratory Standards (NCCLS). Method for dilution antibacterial susceptibility test for bacteria that grow aerobically. Fourth. Approved standard M7-A4. Villanova, PA: NCCLS; 1997.
   Google Scholar
• Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, . In vitro activity of the new quinolone wck 771 against staphylococci. Antimicrob Agents Chemother 2004;48:3338–42.
   PubMed Web of Science ®Google Scholar
• Lomovskaya O, Lee A, Hoshino K, Ishida H, Mistry A, Warren MS, . Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999;43:1340–6.
   PubMed Web of Science ®Google Scholar
• Mullin S, Mani N, Grossman TH. Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (vx-710) and timcodar (vx-853). Antimicrob Agents Chemother 2004;48:4171–6.
   PubMed Web of Science ®Google Scholar
• Lechner D, Gibbons S, Bucar F. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother 2008;62:345–8.
   PubMed Web of Science ®Google Scholar
• Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, . Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 2008;61:1270–6.
   PubMed Web of Science ®Google Scholar
• Shim JY, Chang Y, Kim SU. Indigo and indirubin derivatives from indoles in Polygonum tinctorium tissue cultures. Biotechnol Lett 1998;20:1139–43.
   Google Scholar
• Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, . Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001;276:31475–8.
   PubMed Web of Science ®Google Scholar
• MacNeil IA, Tiong CL, Minor C, August PR, Grossman TH, Loiacono KA, . Expression and isolation of antimicrobial small molecules from soil DNA libraries. J Mol Microbiol Biotechnol 2001;3:301–8.
   PubMed Web of Science ®Google Scholar
• Kaatz GW. Bacterial efflux pump inhibition. Curr Opin Investig Drugs 2005;6:191–8.
   PubMedGoogle Scholar
• Ramon-Garcia S, Martin C, Ainsa JA, De Rossi E. Characterization of tetracycline resistance mediated by the efflux pump tap from Mycobacterium fortuitum. J Antimicrob Chemother 2006;57:252–9.
   PubMed Web of Science ®Google Scholar
• Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007;59:1247–60.
   PubMed Web of Science ®Google Scholar
• Ba BB, Arpin C, Vidaillac C, Chausse A, Saux MC, Quentin C. Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother 2006;50:1931–6.
   PubMed Web of Science ®Google Scholar
• Kristiansen JE, Amaral L. The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 1997;40:319–27.
   PubMed Web of Science ®Google Scholar